Clinical treatment of women with atypical squamous cells of undetermined significance or atypical glandular cells of undetermined significance cervical cytology

Clinical Obstetrics and Gynecology

Volumn 43, Issue 2, 2000, Pages 381-393

  Jones III, Howard W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER RISK; CONFERENCE PAPER; CYTODIAGNOSIS; ENDOMETRIUM CELL; FEMALE; HUMAN; PAPANICOLAOU TEST; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA;

CERVIX UTERI; COLPOSCOPY; FEMALE; HUMANS; TRIAGE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0033922081     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200006000-00017     Document Type: Conference Paper

References (39)

1. Manos MM, Kinney Wk, Hurley LB, et al. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999;281:1605-1610.
2. Davey DD, Naryshkin S, Nielsen ML, et al. Atypical squamous cells of undetermined significance: Intelaboratory comparison and quality assurance monitors. Diagn Cytopathol. 1994;11:390-396.
3. Kinney WK, Manos MM, Hurley LB, et al. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol. 1998;91:973-976.
4. Veljovich DS, Stoler MH, Anderson WH, et al. Atypical glandular cells of undetermined significance: A five-year retrospective histopathologic study. Am J Obstet Gynecol. 1998;179:382-390.
5. Anonymous. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: Revised after the Second National Cancer Institute Workshop. Acta Cytol. 1993;37:115-124.
6. Kurman RJ, Solomon D, eds. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York: Springer-Verlag, 1994:30.
7. Ettler HC, Downing P, Wright VC, Joseph MG. Atypical squamous cells of undetermined significance: A cytohistological study in a colposcopy unit. Lab Invest. 1997;76:33A.
8. Williams ML, Rimm DL, Pedigo MA, et al. Atypical squamous cells of undetermined significance: Correlative histologic and follow-up studies from an academic medical center. Diagn Cytopathol. 1997;16:1-7.
9. Gonzalez D, Hernandez E, Anderson L, et al. Clinical significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. J Reprod Med. 1996;41:719-723.
10. Selvaggi SM, Haefner HK. Reporting of atypical squamous cells of undetermined significance on cervical smears: Is it significant? Diagn Cytopathol 1995;13:352-356.
11. Auger M, Charbonneau M, Arseneau J. Atypical squamous cells of undetermined significance. A cytohistologic study of 52 cases. Acta Cytol. 1997;41:1671-1675.
12. Yang M, Zachariah S. ASCUS on cervical cytologic smears. Clinical significance. J Reprod Med. 1997;42:329-331.
13. Cox JT, Lorinez AT, Schiffman MH, et al. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 1995;172: 946-954.
14. Kobelin MH, Kobelin CG, Burke L, et al. Incidence and predictors of cervical dysplasia in patients with minimally abnormal Papanicolaou smears. Obstet Gynecol. 1998;92:356-359.
15. Kurman RJ, Henson DE, Herbst Al, et al. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA. 1994;271:1866-1869.
16. Management Guidelines ASCUS. The Colposcopist. 1996;27:1-9.
17. Spitzer M, Ryskin M, Chernys AE, Shifrin A. The value of repeat Pap smear at the time of initial colposcopy. Gynecol Oncol. 1997;67:3-7.
18. Ferris DG, Wright TC Jr, Litaker MS, et al. Triage of women with ASCUS and LSIL on Pap smear reports: Management by repeat Pap smear, HPV DNA testing, or colposcopy? (See comments). J Fam Pract. 1998;46:125-134.
19. Shaft MI, Luesley DM, Jordan JA, et al. Randomized trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. Br J Obstet Gynaecol. 1997;104: 590-594.
20. Stoler MH. A brief synopsis of the role of human papillomaviruses in cervical carcinogenesis. Am J Obstet Gynecol. 1996;175:1091-1098.
21. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol. 1995;85:202-210.
22. Reid R, Greenberg MD, Lorincz A, et al. Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol. 1991;164:1461-1469; discussion 1469-1471.
23. Kaufman RH, Adam E, Icenogle J, et al. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol. 1997;176:87-92.
24. Kaufman RH, Adam E. Is human papillomavirus testing of value in clinical practice? Am J Obstet Gynecol. 1999;180:1049-1053.
25. Ferris DG, Wright TC Jr, Litaker MS, et al. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL (see comments). J Fam Pract. 1998;46: 136-141.
26. Stafl A. Cervicography. Clin Obstet Gynecol. 1983;26:1007-1016.
27. Baldauf JJ, Dreyfus M, Ritter J, et al. Cervicography. Does it improve cervical cancer screening? Acta Cytolog. 1997;41:295-301.
28. Schneider DL, Herrero R, Bratti C, et al. Cervicography screening for cervical cancer among 8,460 women in a high-risk population. Am J Obstet Gynecol. 1999;180: 290-298.
29. Eskridge C, Begneaud WP, Landwehr C, et al. Cervicography combined with repeat Papanicolaou test as triage for low-grade cytologic abnormalities. Obstet Gynecol. 1998;92:351-355.
30. Massad LS, Lonky NM, Mutch DG, et al. Use of speculoscopy in the evaluation of women with atypical Papanicolaou smears. Improved cost effectiveness by selective colposcopy. J Reprod Med. 1993;38:163-169.
31. Roland PY, Naumann RW, Alvarez RD, et al. A decision analysis of practice patterns used in evaluating and treating abnormal Pap smears. Gynecol Oncol. 1995;59:75-80.
32. Raab SS, Geisinger KR, Thomas PA, et al. Atypical glandular cells of undetermined significance (AGUS): Interobserver variability of expert cytopathologists. Lab Invest. 1997;76:37A.
33. Wolf JK, Leveback C, Malpica A, et al. Adenocarcinoma in situ of the cervix: Significant of cone biopsy margins. Obstet Gynecol. 1996;88:82-86.
34. Azodi M, Chambers SK, Rutherford TJ, et al. Adenocarcinoma in situ of the cervix: Management and outcome. Gynecol Oncol. 1999;73:348-353.
35. Goff BA, Atanasoff CT, Brown E, et al. Endocervical glandular atypia in Papanico laou smears. Obstet Gynecol. 1992;79:101-104.
36. Kennedy AW, Salamieri SS, Wirth SL, et al. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol. 1996;63:14-18.
37. Zweizig S, Noller K, Real F, et al. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol. 1997;65:314-318.
38. Eddy GL, Strumpf KB, Wojtowycz MA, et al. Biopsy findings in five hundred thirty-one patients with atypical glandular cells of uncertain significance as defined by the Bethesda system. Am J Obstet Gynecol. 1997; 177:1188-1195.
39. Manetta A, Keefe K, Lin F, et al. Atypical glandular cells of undetermined significance in cervical cytological findings. Am J Obstet Gynecol. 1999;180:883-888.